_id

691052a2ccc777a4e85d54d7

Ticker

CODX

Name

Co-Diagnostics Inc

Exchange

NASDAQ

Address

2401 S. Foothill Dr., Salt Lake City, UT, United States, 84109

Country

USA

Sector

Healthcare

Industry

Medical Devices

Currency

USD

Website

https://co-dx.com

Description

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

Last Close

0.3484

Volume

939585

Current Price

0.3414

Change

-2.0091848450057426

Last Updated

2025-11-29T11:43:27.685Z

Image

data:image/webp;base64,UklGRh4BAABXRUJQVlA4IBIBAADQCACdASpAAEAAPrVMokunJCMhrBK8AOAWiWMA03UHQRCARKcyRtme6nbfJuH0voKGvgBD3shC58sPQXIXz1kl8YJVC5XiLM7TnBPfN54AAP749Fq4kGS5LvSt3v4n88qMnphD6QF0bNXIQktNuLI6jFzNqiSLtqxhGftXNtmgRsME+/GSN0cuZvGQRWwoNFH2B0uU/fxbVydQKQkQoWHxycB6npuwSnyuG0MWM9Ed9DurzWDIyjBbugYqLS5Z7O0hm/LehaNXN1m2BSKLBODkVjJ0WyUJ25POuNqUWdwPf8ISWtp+PXA7XMr39kvJGgaJEOsUZ2DIojSCAySopqV+IVFGGPDSkseiAnkzw9B/gAAA

Ipo Date

2017-07-12T00:00:00.000Z

Market Cap

22566790

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8301666666666666

Sentiment Sources

6

Rating

4

Target Price

1.5

Strong Buy

1

Buy

0

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

145380

Cost Of Revenue

26285

Gross Profit

119095

Operating Expenses

7132943

Operating Income

-7013848

Interest Expense

-

Pretax Income

-7053416

Net Income

-5886823

Eps

-0.1553623541976003

Dividends Per Share

-

Shares Outstanding

60892582

Income Tax Expense

-1166593

EBITDA

-6746465

Operating Margin

-4824.493052689503

Total Other Income Expense Net

-39568

Cash

11443943

Short Term Investments

0

Receivables

55905

Inventories

1089956

Total Current Assets

14054967

Property Plant Equipment

3924891

Total Assets

44740761

Payables

1458397

Short Term Debt

744156

Long Term Debt

-

Total Liabilities

4912516

Equity

39828245

Depreciation

267383

Change In Working Capital

-782702

Cash From Operations

-5904585

Capital Expenditures

75105

Cash From Investing

2174895

Cash From Financing

4058452

Net Change In Cash

328762

PE

-

PB

0.3247936511438051

ROE

-14.780523219137576

ROA

-13.157628230775959

FCF

-5979690

Fcf Percent

-41.131448617416424

Piotroski FScore

0

Health Score

33

Deep Value Investing Score

7

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

4

Net Net Investing Score

3.5

Quality Investing Score

3

Value Investing Score

5.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

145380

Quarters > 0 > income Statement > cost Of Revenue

26285

Quarters > 0 > income Statement > gross Profit

119095

Quarters > 0 > income Statement > operating Expenses

7132943

Quarters > 0 > income Statement > operating Income

-7013848

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-7053416

Quarters > 0 > income Statement > net Income

-5886823

Quarters > 0 > income Statement > eps

-0.1553623541976003

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

37890923

Quarters > 0 > income Statement > income Tax Expense

-1166593

Quarters > 0 > income Statement > EBITDA

-6746465

Quarters > 0 > income Statement > operating Margin

-4824.493052689503

Quarters > 0 > income Statement > total Other Income Expense Net

-39568

Quarters > 0 > balance Sheet > cash

11443943

Quarters > 0 > balance Sheet > short Term Investments

0

Quarters > 0 > balance Sheet > receivables

55905

Quarters > 0 > balance Sheet > inventories

1089956

Quarters > 0 > balance Sheet > total Current Assets

14054967

Quarters > 0 > balance Sheet > property Plant Equipment

3924891

Quarters > 0 > balance Sheet > total Assets

44740761

Quarters > 0 > balance Sheet > payables

1458397

Quarters > 0 > balance Sheet > short Term Debt

744156

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

4912516

Quarters > 0 > balance Sheet > equity

39828245

Quarters > 0 > cash Flow > net Income

-5886823

Quarters > 0 > cash Flow > depreciation

267383

Quarters > 0 > cash Flow > change In Working Capital

-782702

Quarters > 0 > cash Flow > cash From Operations

-5904585

Quarters > 0 > cash Flow > capital Expenditures

75105

Quarters > 0 > cash Flow > cash From Investing

2174895

Quarters > 0 > cash Flow > cash From Financing

4058452

Quarters > 0 > cash Flow > net Change In Cash

328762

Quarters > 0 > ratios > PE

-0.1553623541976003

Quarters > 0 > ratios > PB

0.3247936511438051

Quarters > 0 > ratios > ROE

-14.780523219137576

Quarters > 0 > ratios > ROA

-13.157628230775959

Quarters > 0 > ratios > FCF

-5979690

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-41.131448617416424

Quarters > 0 > health Score

33

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

162910

Quarters > 1 > income Statement > cost Of Revenue

32106

Quarters > 1 > income Statement > gross Profit

130804

Quarters > 1 > income Statement > operating Expenses

8188568

Quarters > 1 > income Statement > operating Income

-8057764

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-7717790

Quarters > 1 > income Statement > net Income

-7730117

Quarters > 1 > income Statement > eps

-0.2334790335225814

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

33108399

Quarters > 1 > income Statement > income Tax Expense

12327

Quarters > 1 > income Statement > EBITDA

-7766350

Quarters > 1 > income Statement > operating Margin

-4946.144496961512

Quarters > 1 > income Statement > total Other Income Expense Net

339974

Quarters > 1 > balance Sheet > cash

11115181

Quarters > 1 > balance Sheet > short Term Investments

2247638

Quarters > 1 > balance Sheet > receivables

210968

Quarters > 1 > balance Sheet > inventories

1084627

Quarters > 1 > balance Sheet > total Current Assets

15307166

Quarters > 1 > balance Sheet > property Plant Equipment

4341806

Quarters > 1 > balance Sheet > total Assets

46465833

Quarters > 1 > balance Sheet > payables

1635196

Quarters > 1 > balance Sheet > short Term Debt

824458

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

5327439

Quarters > 1 > balance Sheet > equity

41138394

Quarters > 1 > cash Flow > net Income

-7730117

Quarters > 1 > cash Flow > depreciation

291414

Quarters > 1 > cash Flow > change In Working Capital

-1158763

Quarters > 1 > cash Flow > cash From Operations

-8287830

Quarters > 1 > cash Flow > capital Expenditures

401060

Quarters > 1 > cash Flow > cash From Investing

17070977

Quarters > 1 > cash Flow > cash From Financing

429000

Quarters > 1 > cash Flow > net Change In Cash

9212147

Quarters > 1 > ratios > PE

-0.2334790335225814

Quarters > 1 > ratios > PB

0.2747605416633425

Quarters > 1 > ratios > ROE

-18.79051719909144

Quarters > 1 > ratios > ROA

-16.636131326861182

Quarters > 1 > ratios > FCF

-8688890

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-53.33552268123504

Quarters > 1 > health Score

33

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

50277

Quarters > 2 > income Statement > cost Of Revenue

21590

Quarters > 2 > income Statement > gross Profit

28687

Quarters > 2 > income Statement > operating Expenses

8580643

Quarters > 2 > income Statement > operating Income

-8551956

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-7521267

Quarters > 2 > income Statement > net Income

-7533271

Quarters > 2 > income Statement > eps

-0.23505513581052087

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

32048953

Quarters > 2 > income Statement > income Tax Expense

12004

Quarters > 2 > income Statement > EBITDA

-8271511

Quarters > 2 > income Statement > operating Margin

-17009.67838176502

Quarters > 2 > income Statement > total Other Income Expense Net

1030689

Quarters > 2 > balance Sheet > cash

1903034

Quarters > 2 > balance Sheet > short Term Investments

19575902

Quarters > 2 > balance Sheet > receivables

136391

Quarters > 2 > balance Sheet > inventories

1083309

Quarters > 2 > balance Sheet > total Current Assets

23831491

Quarters > 2 > balance Sheet > property Plant Equipment

4487230

Quarters > 2 > balance Sheet > total Assets

55149342

Quarters > 2 > balance Sheet > payables

2712642

Quarters > 2 > balance Sheet > short Term Debt

902881

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

7228511

Quarters > 2 > balance Sheet > equity

47920831

Quarters > 2 > cash Flow > net Income

-7533271

Quarters > 2 > cash Flow > depreciation

280445

Quarters > 2 > cash Flow > change In Working Capital

-1317788

Quarters > 2 > cash Flow > cash From Operations

-8745214

Quarters > 2 > cash Flow > capital Expenditures

91913

Quarters > 2 > cash Flow > cash From Investing

7356958

Quarters > 2 > cash Flow > cash From Financing

354746

Quarters > 2 > cash Flow > net Change In Cash

-1033510

Quarters > 2 > ratios > PE

-0.23505513581052087

Quarters > 2 > ratios > PB

0.22832476661767406

Quarters > 2 > ratios > ROE

-15.72024283134823

Quarters > 2 > ratios > ROA

-13.659765877170393

Quarters > 2 > ratios > FCF

-8837127

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-175.7687809535175

Quarters > 2 > health Score

33

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

149325

Quarters > 3 > income Statement > cost Of Revenue

255068

Quarters > 3 > income Statement > gross Profit

-105743

Quarters > 3 > income Statement > operating Expenses

11801281

Quarters > 3 > income Statement > operating Income

-11907024

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-11039367

Quarters > 3 > income Statement > net Income

-11031192

Quarters > 3 > income Statement > eps

-0.3337370419341418

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

33053544

Quarters > 3 > income Statement > income Tax Expense

-8175

Quarters > 3 > income Statement > EBITDA

-11549901

Quarters > 3 > income Statement > operating Margin

-7973.898543445504

Quarters > 3 > income Statement > total Other Income Expense Net

867657

Quarters > 3 > balance Sheet > cash

2936544

Quarters > 3 > balance Sheet > short Term Investments

26811098

Quarters > 3 > balance Sheet > receivables

132570

Quarters > 3 > balance Sheet > inventories

1072724

Quarters > 3 > balance Sheet > total Current Assets

32291697

Quarters > 3 > balance Sheet > property Plant Equipment

4876156

Quarters > 3 > balance Sheet > total Assets

63999919

Quarters > 3 > balance Sheet > payables

3294254

Quarters > 3 > balance Sheet > short Term Debt

915619

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

9688001

Quarters > 3 > balance Sheet > equity

54311918

Quarters > 3 > cash Flow > net Income

-11031192

Quarters > 3 > cash Flow > depreciation

357123

Quarters > 3 > cash Flow > change In Working Capital

1729126

Quarters > 3 > cash Flow > cash From Operations

-8231006

Quarters > 3 > cash Flow > capital Expenditures

72987

Quarters > 3 > cash Flow > cash From Investing

266006

Quarters > 3 > cash Flow > cash From Financing

103914

Quarters > 3 > cash Flow > net Change In Cash

-7861086

Quarters > 3 > ratios > PE

-0.3337370419341418

Quarters > 3 > ratios > PB

0.20777170715274682

Quarters > 3 > ratios > ROE

-20.310812812760542

Quarters > 3 > ratios > ROA

-17.236259314640694

Quarters > 3 > ratios > FCF

-8303993

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-55.61019922986774

Quarters > 3 > health Score

34

Valuation > metrics > PE

-0.1553623541976003

Valuation > metrics > PB

0.3247936511438051

Valuation > final Score

70

Valuation > verdict

67.5% Undervalued

Profitability > metrics > ROE

-14.780523219137576

Profitability > metrics > ROA

-41.88428902038688

Profitability > metrics > Net Margin

-40.49266061356445

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.1233425173516935

Risk > metrics > Interest Coverage

-22.850057501034367

Risk > final Score

-31

Risk > verdict

High

Liquidity > metrics > Current Ratio

6.381216252230934

Liquidity > metrics > Quick Ratio

5.886355969640685

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-604

Prev Risks > 1

14

Prev Risks > 2

-33

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:21:22.143Z